Erythroid heme biosynthesis and its disorders

• Published in: Cold Spring Harbor perspectives in medicine Vol. 3; no. 4; p. a011676
• Main Authors: Dailey, Harry A, Meissner, Peter N
• Format: Journal Article
• Language: English
• Published: United States Cold Spring Harbor Laboratory Press 01-04-2013
• Subjects: Coproporphyrinogens - metabolism; Enzymes - physiology; Erythropoiesis - physiology; Hematologic Diseases - enzymology; Hematologic Diseases - etiology; Heme - biosynthesis; Humans; Mitochondria - metabolism
• ISSN: 2157-1422; 2472-5412
• DOI: 10.1101/cshperspect.a011676

Heme, which is composed of iron and the small organic molecule protoporphyrin, is an essential component of hemoglobin as well as a variety of physiologically important hemoproteins. During erythropoiesis, heme synthesis is induced before, and is essential for, globin synthesis. Although all cells possess the ability to synthesize heme, there are distinct differences between regulation of the pathway in developing erythroid cells and all other types of cells. Disorders that compromise the ability of the developing red cell to synthesize heme can have profound medical implications. The biosynthetic pathway for heme and key regulatory features are reviewed herein, along with specific human genetic disorders that arise from defective heme synthesis such as X-linked sideroblastic anemia and erythropoietic protoporphyria.